UNC-School of Medicine: Study Finds Oral Semaglutide Vastly Reduces Heart Attacks, Strokes
April 01, 2025
April 01, 2025
CHAPEL HILL, North Carolina, April 1 -- The University of North Carolina School of Medicine issued the following news release:
* * *
Study Finds Oral Semaglutide Vastly Reduces Heart Attacks, Strokes
A large clinical trial, co-led by researchers at the UNC School of Medicine, has shown that the popular weight-loss drug significantly reduces cardiovascular events in people with type 2 diabetes, pre-existing cardiovascular disease, and/or chronic kidney disea . . .
* * *
Study Finds Oral Semaglutide Vastly Reduces Heart Attacks, Strokes
A large clinical trial, co-led by researchers at the UNC School of Medicine, has shown that the popular weight-loss drug significantly reduces cardiovascular events in people with type 2 diabetes, pre-existing cardiovascular disease, and/or chronic kidney disea . . .